Los Angeles Times - October 11, 2002
Charles Ornstein, Times Staff Writer
California regulators have rejected a request by Kaiser Permanente, the state's largest HMO, to set limits as low as $500 on coverage for prescription drugs in some insurance policies.
Daniel Zingale, director of the California Department of Managed Health Care, said he was deeply troubled by Kaiser's proposal because it could have denied patients access to lifesaving drugs.
Zingale said his agency is conscious of the growing cost of prescription drugs but he added that cost-cutting efforts must be designed so they don't endanger people.
"A person living with HIV faces drug bills of $15,000 per year to stay alive," Zingale wrote in a letter Wednesday to Kaiser Chairman and Chief Executive George Halvorson.
"The Kaiser proposal could force many people with HIV, under the impression that their health-care investment covers lifesaving drugs, to choose between food and medication," Zingale wrote.
"No one with heart disease, cancer, diabetes or HIV should be denied lifesaving drugs."
Kaiser spokesman Matthew Schiffgens said the health maintenance organization had withdrawn its request on Tuesday, a day before Zingale sent his letter rejecting it. Even so, Schiffgens said, the insurer views drug caps as reasonable, given the current realities of medical economics.
"We think that these are useful and responsive tools for balancing the rapidly escalating cost of pharmaceuticals and the imperative to keep insurance premiums affordable for California's health-care consumers," Schiffgens said. "It's clearly been demonstrated that when health insurance premiums increase, consumers begin to decide that they can't afford coverage."
Under Kaiser's proposal, the caps would have applied to some members of Kaiser's individual and small-group policies.
California law allows insurers to sell individual policies that include no drug benefit at all. But once a plan includes any prescription coverage, certain minimum standards apply, such as mandatory coverage of diabetes drugs, contraceptives and pain management medications.
Zingale's action is just the latest in his agency's battle with California HMOs over coverage for prescription drugs. In January, a judge in Sacramento ruled that the agency could not force Blue Shield of California to provide a weight-loss drug to an obese member. In July 2001, another judge said the state could not require Kaiser Permanente to cover Viagra or other drugs to remedy sexual dysfunction.
Those court losses prompted the Legislature to approve a bill this year that gives Zingale's agency explicit authority to regulate prescription drug benefits offered by HMOs. Gov. Gray Davis signed the bill, despite opposition from Kaiser and the insurance industry.
Nearly all insurers place dollar limits on drug spending for senior citizens in Medicare HMOs, which aren't regulated by Zingale's office. But experience has shown that patients with chronic conditions quickly use up their benefits and then face thousands of dollars in out-of-pocket expenses.
Zingale said his agency will soon begin a study to determine when caps are appropriate and how low they should be set. Zingale's predecessors allowed drug caps as low as $1,000 for some Kaiser policies, but he plans to re-evaluate them with his new legislative authority.
Kaiser, which insures 6.3 million Californians, said it will continue trying to make drug coverage affordable and accessible. "Affordability is a very important issue," Schiffgens said.
021011
LT021003
Copyright © 2002 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .